Trial Profile
Prospective, Randomized, Controlled Arm Study Comparing the Coverage of the Zotarolimus-Eluting Stent vs [versus] Bare Metal Stent Implanted in ST- Elevation Myocardial Infarction (STEMI)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 May 2022
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms OCTAMI
- 12 Feb 2010 Actual number of patients (44) added as reported by ClinicalTrials.gov record.
- 12 Feb 2010 Actual end date (1 Oct 2009) added as reported by ClinicalTrials.gov record.
- 12 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.